Matches in Wikidata for { <http://www.wikidata.org/entity/Q101137154> ?p ?o ?g. }
- Q101137154 description "2020 nî lūn-bûn" @default.
- Q101137154 description "2020年の論文" @default.
- Q101137154 description "2020年学术文章" @default.
- Q101137154 description "2020年学术文章" @default.
- Q101137154 description "2020年学术文章" @default.
- Q101137154 description "2020年学术文章" @default.
- Q101137154 description "2020年学术文章" @default.
- Q101137154 description "2020年学术文章" @default.
- Q101137154 description "2020年學術文章" @default.
- Q101137154 description "2020年學術文章" @default.
- Q101137154 description "2020年學術文章" @default.
- Q101137154 description "2020年學術文章" @default.
- Q101137154 description "2020年學術文章" @default.
- Q101137154 description "2020년 논문" @default.
- Q101137154 description "article científic" @default.
- Q101137154 description "article scientific" @default.
- Q101137154 description "article scientifique" @default.
- Q101137154 description "articol științific" @default.
- Q101137154 description "articolo scientifico" @default.
- Q101137154 description "artigo científico" @default.
- Q101137154 description "artigo científico" @default.
- Q101137154 description "artigo científico" @default.
- Q101137154 description "artikel ilmiah" @default.
- Q101137154 description "artikull shkencor" @default.
- Q101137154 description "artikulong pang-agham" @default.
- Q101137154 description "artykuł naukowy" @default.
- Q101137154 description "artículo científico publicado en 2020" @default.
- Q101137154 description "artículu científicu" @default.
- Q101137154 description "bilimsel makale" @default.
- Q101137154 description "bài báo khoa học" @default.
- Q101137154 description "naučni članak" @default.
- Q101137154 description "scienca artikolo" @default.
- Q101137154 description "scientific article published on 29 October 2020" @default.
- Q101137154 description "scientific article published on 29 October 2020" @default.
- Q101137154 description "scientific article published on 29 October 2020" @default.
- Q101137154 description "teaduslik artikkel" @default.
- Q101137154 description "tieteellinen artikkeli" @default.
- Q101137154 description "tudományos cikk" @default.
- Q101137154 description "vedecký článok" @default.
- Q101137154 description "vetenskaplig artikel" @default.
- Q101137154 description "videnskabelig artikel udgivet 29. oktober 2020" @default.
- Q101137154 description "vitenskapelig artikkel" @default.
- Q101137154 description "vitskapeleg artikkel" @default.
- Q101137154 description "vědecký článek" @default.
- Q101137154 description "wetenschappelijk artikel" @default.
- Q101137154 description "wissenschaftlicher Artikel" @default.
- Q101137154 description "επιστημονικό άρθρο" @default.
- Q101137154 description "мақолаи илмӣ" @default.
- Q101137154 description "наукова стаття, опублікована в жовтні 2020" @default.
- Q101137154 description "научна статия" @default.
- Q101137154 description "научная статья" @default.
- Q101137154 description "научни чланак" @default.
- Q101137154 description "научни чланак" @default.
- Q101137154 description "מאמר מדעי" @default.
- Q101137154 description "مقالة علمية نشرت في 29 أكتوبر 2020" @default.
- Q101137154 description "২৯ অক্টোবর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q101137154 description "บทความทางวิทยาศาสตร์" @default.
- Q101137154 description "სამეცნიერო სტატია" @default.
- Q101137154 name "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 name "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 name "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 type Item @default.
- Q101137154 label "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 label "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 label "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 prefLabel "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 prefLabel "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 prefLabel "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 P1433 Q101137154-D73EE13B-78C7-43CE-9506-EC5280A6F23C @default.
- Q101137154 P1476 Q101137154-3F1F3474-BCD3-4C02-8861-2DD995113A44 @default.
- Q101137154 P2093 Q101137154-114C6658-EECA-4F39-8D8A-6E3DC9D50F07 @default.
- Q101137154 P2093 Q101137154-129339ED-9292-4BD9-B307-78D3991FC457 @default.
- Q101137154 P2093 Q101137154-3F063FAD-A0F2-4905-AD8B-9B31935CDF0F @default.
- Q101137154 P2093 Q101137154-44E002A4-FB22-42CC-BE68-E3CFF4179674 @default.
- Q101137154 P2093 Q101137154-75B71C3E-7D69-49A0-BA8A-BE46F93038B8 @default.
- Q101137154 P2093 Q101137154-88195DE6-2A6B-4D45-A6A4-79A6E2FE991B @default.
- Q101137154 P2093 Q101137154-A707596A-AF90-40B1-BA52-C03E5A91A363 @default.
- Q101137154 P2093 Q101137154-E16C22D1-7312-4B6D-B087-5055FBC11D76 @default.
- Q101137154 P31 Q101137154-2169C266-0164-4E43-9D83-00F0E6AB5114 @default.
- Q101137154 P356 Q101137154-0F790BA3-1661-4853-856F-87EE8A9F09DE @default.
- Q101137154 P50 Q101137154-0F0ADB0E-ADFD-43BF-BD99-35918CBB3DAB @default.
- Q101137154 P50 Q101137154-470308B6-BB3C-4584-B54C-8DC56DFCA79B @default.
- Q101137154 P50 Q101137154-4E65B43D-FB7A-4325-BF45-412896B11D92 @default.
- Q101137154 P50 Q101137154-9A5CF98E-3E4D-4405-9119-D36F0CC80A54 @default.
- Q101137154 P50 Q101137154-A0A67314-3853-40CB-9D40-835DEE3929E9 @default.
- Q101137154 P50 Q101137154-A3E1D62A-A492-484E-8A32-1BA1A733CDE7 @default.
- Q101137154 P577 Q101137154-4CEA24AB-392C-4F99-850C-682170B31EAF @default.
- Q101137154 P698 Q101137154-6C3FF30F-075A-4639-B364-AEBD355D3219 @default.
- Q101137154 P921 Q101137154-185480AD-8EE2-4FDA-9317-D70F201A2D8F @default.
- Q101137154 P356 S1474-4422(20)30342-2 @default.
- Q101137154 P698 33129442 @default.
- Q101137154 P1433 Q15755067 @default.
- Q101137154 P1476 "Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial" @default.
- Q101137154 P2093 "Bruno Brochet" @default.
- Q101137154 P2093 "Douglas L Arnold" @default.
- Q101137154 P2093 "Hans-Peter Hartung" @default.
- Q101137154 P2093 "Harold Koendgen" @default.
- Q101137154 P2093 "Iain Bennett" @default.
- Q101137154 P2093 "James Overell" @default.
- Q101137154 P2093 "Jerry S Wolinsky" @default.